Northern Trust’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3K | Hold |
61,605
| – | – | ﹤0.01% | 4341 |
|
|
2025
Q1 | $18.8K | Hold |
61,605
| – | – | ﹤0.01% | 4343 |
|
|
2024
Q4 | $177K | Hold |
61,605
| – | – | ﹤0.01% | 4024 |
|
|
2024
Q3 | $158K | Sell |
61,605
-401
| -0.6% | -$1.03K | ﹤0.01% | 3951 |
|
|
2024
Q2 | $122K | Buy |
62,006
+16,791
| +37% | +$32.9K | ﹤0.01% | 4001 |
|
|
2024
Q1 | $120K | Buy |
45,215
+657
| +1% | +$1.75K | ﹤0.01% | 4028 |
|
|
2023
Q4 | $185K | Buy |
44,558
+16,412
| +58% | +$68K | ﹤0.01% | 3924 |
|
|
2023
Q3 | $38.8K | Buy |
28,146
+12,853
| +84% | +$17.7K | ﹤0.01% | 4227 |
|
|
2023
Q2 | $47.9K | Hold |
15,293
| – | – | ﹤0.01% | 4230 |
|
|
2023
Q1 | $52K | Buy |
15,293
+2,637
| +21% | +$8.97K | ﹤0.01% | 4256 |
|
|
2022
Q4 | $57K | Hold |
12,656
| – | – | ﹤0.01% | 4250 |
|
|
2022
Q3 | $111K | Buy |
12,656
+1,544
| +14% | +$13.5K | ﹤0.01% | 4080 |
|
|
2022
Q2 | $128K | Hold |
11,112
| – | – | ﹤0.01% | 4080 |
|
|
2022
Q1 | $194K | Hold |
11,112
| – | – | ﹤0.01% | 4142 |
|
|
2021
Q4 | $360K | Buy |
11,112
+3,717
| +50% | +$120K | ﹤0.01% | 3936 |
|
|
2021
Q3 | $297K | Sell |
7,395
-1,111
| -13% | -$44.6K | ﹤0.01% | 3987 |
|
|
2021
Q2 | $140K | Hold |
8,506
| – | – | ﹤0.01% | 4273 |
|
|
2021
Q1 | $162K | Buy |
8,506
+379
| +5% | +$7.22K | ﹤0.01% | 4168 |
|
|
2020
Q4 | $183K | Buy |
8,127
+1,789
| +28% | +$40.3K | ﹤0.01% | 3986 |
|
|
2020
Q3 | $125K | Buy |
6,338
+1,703
| +37% | +$33.6K | ﹤0.01% | 3916 |
|
|
2020
Q2 | $97K | Buy |
4,635
+2,359
| +104% | +$49.4K | ﹤0.01% | 3928 |
|
|
2020
Q1 | $36K | Hold |
2,276
| – | – | ﹤0.01% | 4004 |
|
|
2019
Q4 | $25K | Hold |
2,276
| – | – | ﹤0.01% | 4140 |
|
|
2019
Q3 | $27K | Buy |
+2,276
| New | +$27K | ﹤0.01% | 4132 |
|